Use the Back button in your browser to see the other results of your search or to select another record.
Is a longer time interval between recombinant human deoxyribonuclease (dornase alfa) and chest physiotherapy better: a multi-center, randomized crossover trial |
Wilson CJ, Robbins LJ, Murphy JM, Chang AB |
Pediatric Pulmonology 2007 Dec;42(12):1110-1116 |
clinical trial |
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|